Latest P/E ratio for InspireMD- Warrants: 0.0 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow0.00
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
InspireMD- Warrants (NSPRZ) currently reports a P/E ratio of 0.0. That is below the Healthcare sector average of 25.9. Use the charts on this page to explore InspireMD- Warrants's P/E ratio history and peer comparisons.
InspireMD- Warrants's P/E ratio of 0.0 is lower than the Healthcare sector average of 25.9. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates InspireMD- Warrants's market price to a fundamental measure such as earnings, sales, or book value. At 0.0, NSPRZ can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 0.0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for InspireMD- Warrants, and consider following NSPRZ for alerts when major investors trade the stock.
InspireMD- Warrants is classified in the Healthcare sector. On P/E ratio, it currently shows 0.0 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NSPRZ with unrelated industries.